It has been about a month since the last earnings report for Humana (HUM). Shares have lost about 8.5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

A new study published in the current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP)—conducted by a Humana Healthcare Research team and Dr.

Centene CEO Sarah London highlighted a sharp decline in Affordable Care Act marketplace membership at the Barclays Healthcare ...

The Oncology Institute Inc (TOI) reports a milestone quarter with significant revenue growth and strategic expansions, ...

Healthcare shares posted small losses to close out the week. It was a strong day in the markets for big insurers such as Humana and UnitedHealth. Large drugmakers such as Johnson & Johnson and Eli ...

A research team associated with the European project DEATHREVOL has published a study in the journal Scientific Reports that proposes new analytical tools to better understand how fractures of the ...

Washington: Pfizer, Teva and other major drugmakers have failed to persuade a federal judge to disqualify a former prosecutor ...

Last summer, the Trump administration announced a voluntary pledge by health insurers to reform prior authorization, which often requires patients or their doctors to seek preapproval from insurers ...

Up until the latest Middle East conflict began at the end of February, a quiet trend was emerging among investors, looking ...

Un exmiembro de la Guardia Nacional del Ejército que había pasado ocho años en prisión por intentar ayudar al grupo Estado ...

Q4 2025 Management View Daniel Virnich, CEO & Executive Director, opened the call by highlighting that "the fourth quarter marked an important milestone being our first profitable quarter as a public ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals ...